{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:33:09Z","timestamp":1747157589389,"version":"3.40.5"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.cjca.2019.02.025","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T11:56:06Z","timestamp":1551786966000},"page":"692-693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Continuation of Trickle-Down Medicine: Soluble Suppression of Tumorigenicity-2 (sST2) in Pediatric Heart\u00a0Failure"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6981-1720","authenticated-orcid":false,"given":"Steven C.","family":"Greenway","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2019.02.025_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cjca.2019.02.016","article-title":"Association of soluble ST2 serum levels with outcomes in pediatric dilated cardiomyopathy","volume":"35","author":"You","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.02.025_bib2","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1161\/01.CIR.0000038705.69871.D9","article-title":"Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction","volume":"106","author":"Weinberg","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.02.025_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.cjca.2019.02.025_bib4","doi-asserted-by":"crossref","first-page":"3b","DOI":"10.1016\/j.amjcard.2015.01.034","article-title":"The biology of ST2: the International ST2 Consensus Panel","volume":"115","author":"Pascual-Figal","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2019.02.025_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.hfc.2017.08.005","article-title":"Soluble ST2 in heart failure","volume":"14","author":"McCarthy","year":"2018","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.cjca.2019.02.025_bib6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jchf.2016.09.010","article-title":"Prognostic value of soluble suppression of tumorigenicity-2 in chronic heart failure: a meta-analysis","volume":"5","author":"Aimo","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2019.02.025_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jchf.2016.12.016","article-title":"Meta-analysis of soluble suppression of tumorigenicity-2 and prognosis in acute heart failure","volume":"5","author":"Aimo","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2019.02.025_bib8","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.jacc.2017.09.031","article-title":"Soluble ST2 for prognosis and monitoring in heart failure: the new gold standard?","volume":"70","author":"Bayes-Genis","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.02.025_bib9","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.clinbiochem.2015.08.007","article-title":"Soluble ST2 and galectin-3 in pediatric patients without heart failure","volume":"48","author":"Meeusen","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cjca.2019.02.025_bib10","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1136\/heartjnl-2016-309460","article-title":"Diagnostic performance and reference values of novel biomarkers of paediatric heart failure","volume":"102","author":"Hauser","year":"2016","journal-title":"Heart"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19301497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19301497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:59:38Z","timestamp":1559149178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X19301497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0828282X19301497"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2019.02.025","relation":{},"ISSN":["0828-282X"],"issn-type":[{"type":"print","value":"0828-282X"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Continuation of Trickle-Down Medicine: Soluble Suppression of Tumorigenicity-2 (sST2) in Pediatric Heart\u00a0Failure","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2019.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}